According to market observers, shares of the company are available at a premium of ₹18 in the grey market today ...

Sai Life Sciences IPO price band is fixed at ₹522 to ₹549 per share. At the upper-end of the price band, the company plans to ...

BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and ...

The IPO received strong demand from qualified institutional buyers (QIBs). The current grey market premium (GMP) of the IPO ...

科罗拉多州威斯敏斯特市—TriSalus Life Sciences, Inc. (NASDAQ:TLSI)的董事Arjun JJ Desai最近出售了30,000股公司普通股。根据SEC文件报告，这笔交易发生于2024年12月10日，总价值约为110,700美元。

Sai Life Sciences' Rs 3,042 crore IPO was oversubscribed 1.25 times on its second day, driven by institutional investors. The ...

Sai Life Sciences Ltd.'s initial public offering entered its final day for subscription on Friday. It was subscribed 1.65 ...

专注于体外和体内诊断物质的Achieve Life Sciences, Inc. (NASDAQ:ACHV)，市值1.57亿美元，今天宣布任命Mark K. Oki为新任首席财务官，上周四生效。根据 InvestingPro 数据，该公司保持强劲的流动性，流动比率为6.78倍，但面临现金快速消耗的挑战。Oki先生从其在制药和生命科学板块的前任职位带来了丰富的经验。

Sai Life Sciences Ltd's Rs 3,043-crore IPO saw a remarkable 10.26 times subscription on the final day. The company's shares ...

北京时间2024年12月11日00时42分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价大幅下跌5.03%。截至发稿，该股报1.51美元/股，成交量44.4207万股， 换手率 0.26%，振幅5.03%。

Today is the third and last day for the initial public offering (IPO) of contract research, development, and manufacturing ...

北京时间2024年12月04日01时48分，Atai Life Sciences N.V.（ATAI.us）股票出现波动，股价急速下挫5.03%。截至发稿，该股报1.61美元/股，成交量68.9255万股， 换手率 0.41%，振幅4.14%。